X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

XOMAP

Closed

Xoma Corp

25.9
0.0 (0.00%)
Last Update: 24 Dec 2024 17:30:00
Yesterday: 25.9
Day's Range: 25.9 - 25.9
Send
When Written:
 
24.2501
XOMA Corp is a biotechnology company that specializes in the discovery and development of therapeutic antibodies. The company was founded in 1981 and is headquartered in Emeryville, California. XOMA has a portfolio of proprietary and partnered programs that address a range of diseases, including cancer, infectious diseases, and inflammatory disorders. The company's lead product is gevokizumab, a monoclonal antibody that targets interleukin-1 beta, which is being developed for the treatment of multiple inflammatory and autoimmune diseases. XOMA has collaborations with several pharmaceutical companies, including Novartis, Pfizer, and Takeda, to develop and commercialize its products. The company has a market capitalization of approximately $225 million as of 2021.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:3.15.225.164
X